MAVIRET is the first and only oral eight-week pan-genotypic treatment option approved for people with acute or chronic ...

The deals tout significant discounts for people who pay out of pocket for certain medications. But most people with insurance ...

A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use ...

Researchers at the University of Washington have developed a rapid test that quickly detects hepatitis C, but insurance ...

Kerala has hit its highest number of Hepatitis A cases particularly coming from districts like Ernakulam Malappuram Kozhikode ...

Across the Bay Area, coroners are reporting about half as many overdose deaths from the synthetic opioid fentanyl than during ...

New Mexico will not follow suit after the U.S. Department of Health and Human Services cut down the list of recommended ...

A Wigan and Leigh drug and alcohol charity has been able to announce the micro-elimination of hepatitis C ahead of the NHS ...

GSK's antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, has hit the mark in two phase 3 trials and will be filed for approval as a potential first-in-class treatment for the disease.

Pilot scheme part of authorities’ efforts to meet World Health Organization goal of eliminating viral hepatitis as a public ...

Federal health officials upended the immunization schedule for American children this week. These are the diseases affected.

A recent federal decision to change how newborns receive the hepatitis B vaccine has raised concerns among Missouri health leaders, who warn the shift could put Black and low-income babies at higher ...